Your browser doesn't support javascript.
loading
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.
Pasquini, Marcelo C; Le-Rademacher, Jennifer; Zhu, Xiaochun; Artz, Andrew; DiPersio, John; Fernandez, Hugo F; Mineishi, Shin; Kamishohara, Masaru; Mehta, Jayesh; Nakamura, Yuki; Ratanatharathorn, Voravit; Sobecks, Ronald; Burkart, Jeanne; Bredeson, Christopher.
Afiliação
  • Pasquini MC; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mpasquini@mcw.edu.
  • Le-Rademacher J; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Zhu X; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Artz A; Section of Hematology/Oncology, University of Chicago School of Medicine, Chicago, Illinois.
  • DiPersio J; Department of Hematology/Oncology, Barnes Jewish Hospital, St. Louis, Missouri.
  • Fernandez HF; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Mineishi S; Bone Marrow Transplant Program, University of Alabama at Birmingham, Birmingham, Alabama.
  • Kamishohara M; Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
  • Mehta J; Department of Hematology/ Oncology, Northwestern Memorial Hospital, Chicago, Illinois.
  • Nakamura Y; Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
  • Ratanatharathorn V; Department of Clinical Arrangements, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; J.P. McCarthy Cord Stem Cell Bank, Detroit, Michigan.
  • Sobecks R; Department of Hematopoietic Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Burkart J; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bredeson C; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Biol Blood Marrow Transplant ; 22(8): 1424-1430, 2016 08.
Article em En | MEDLINE | ID: mdl-27154848

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos